Pharming (PHAR) Free Cash Flow (2019 - 2025)
Pharming (PHAR) posted Free Cash Flow of $11.5 million for Q4 2025, up 1239.9% on a QoQ basis from -$1.0 million in Q4 2024, and up 1239.9% year-over-year from $854988.9 in Q4 2024.
Pharming (PHAR) Free Cash Flow (2019 - 2025) Analysis & Trends
Pharming's Free Cash Flow history runs 7 years deep, the most recent figure standing at $11.5 million for Q4 2025.
- Quarterly Free Cash Flow rose 1239.9% year-over-year to $11.5 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $11.5 million (up 25.85% YoY) and the FY2025 annual result came in at $54.0 million, up 2179.34% from the prior year.
- Free Cash Flow was $11.5 million for Q4 2025 at Pharming, up from -$1.0 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $13.0 million in Q3 2022 and bottomed at -$31.4 million in Q2 2023.
- A 5-year average of -$170275.0 and a median of $2.2 million in 2022 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2022 — Free Cash Flow jumped 1643.52% — and 2023, when it plunged 2041.86%.
- Pharming's Free Cash Flow stood at $46859.3 in 2021, then soared by 1643.52% to $817000.0 in 2022, then plunged by 2041.86% to -$15.9 million in 2023, then surged by 93.67% to -$1.0 million in 2024, then soared by 1239.9% to $11.5 million in 2025.
- Business Quant data shows PHAR's Free Cash Flow at $11.5 million in Q4 2025, -$1.0 million in Q4 2024, and $10.1 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | Pharming | 9.02 Bn | 8.96 Bn | 65.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.46 Mn |
| Dec 31, 2025 | 11.46 Mn |
| Dec 31, 2024 | -1.01 Mn |
| Dec 31, 2024 | -1.01 Mn |
| Sep 30, 2024 | 10.11 Mn |
| Sep 30, 2024 | 10.11 Mn |
| Dec 31, 2023 | -15.87 Mn |
| Dec 31, 2023 | -15.87 Mn |
| Sep 30, 2023 | 3.67 Mn |
| Sep 30, 2023 | 3.67 Mn |
| Jun 30, 2023 | -31.42 Mn |
| Jun 30, 2023 | -31.42 Mn |
| Dec 31, 2022 | 817,000.00 |
| Dec 31, 2022 | 817,000.00 |
| Sep 30, 2022 | 12.96 Mn |
| Sep 30, 2022 | 12.96 Mn |
| Dec 31, 2021 | 46,859.34 |
| Dec 31, 2021 | 46,859.34 |
| Sep 30, 2021 | 7.53 Mn |
| Sep 30, 2021 | 7.53 Mn |